11.66
전일 마감가:
$12.42
열려 있는:
$12.435
하루 거래량:
3.18M
Relative Volume:
1.62
시가총액:
$793.99M
수익:
$2.73B
순이익/손실:
$-1.13B
주가수익비율:
-0.6998
EPS:
-16.6622
순현금흐름:
$-83.00M
1주 성능:
-3.00%
1개월 성능:
-32.41%
6개월 성능:
-57.40%
1년 성능:
-57.89%
Quidelortho Corp Stock (QDEL) Company Profile
명칭
Quidelortho Corp
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
QDEL
Quidelortho Corp
|
11.66 | 845.75M | 2.73B | -1.13B | -83.00M | -16.66 |
|
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-09-19 | 재개 | UBS | Neutral |
| 2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
| 2022-09-19 | 개시 | Citigroup | Neutral |
| 2022-07-20 | 개시 | UBS | Sell |
| 2022-06-17 | 재개 | JP Morgan | Neutral |
| 2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | 재확인 | Barclays | Overweight |
| 2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
| 2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | 재확인 | Canaccord Genuity | Hold |
| 2017-02-17 | 개시 | CL King | Neutral |
| 2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | 재확인 | Barclays | Overweight |
| 2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | 개시 | Barclays | Overweight |
| 2013-07-31 | 재확인 | Canaccord Genuity | Buy |
| 2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corp 주식(QDEL)의 최신 뉴스
QuidelOrtho Q1 2026 slides: revenue falls 13%, respiratory weakness pressures margins - Investing.com Nigeria
QuidelOrtho Q1 Earnings Call Highlights - Yahoo Finance
QuidelOrtho (QDEL) Q1 2026 Earnings Transcript - AOL.com
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: QuidelOrtho Q1 2026 results miss expectations - Investing.com
Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q1 Revenue $619.8M, vs. FactSet Est of $665.2M - marketscreener.com
QuidelOrtho (NASDAQ:QDEL) Misses Q1 CY2026 Revenue Estimates - StockStory
QuidelOrtho Corp (NASDAQ:QDEL) Misses Q1 2026 Estimates, Shares Slide 2.7% - ChartMill
QuidelOrtho: Q1 Earnings Snapshot - kens5.com
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q1 Adjusted Loss $0.04 per Share - marketscreener.com
A weak respiratory season hit QuidelOrtho as its 2026 targets fell - Stock Titan
QuidelOrtho (NASDAQ: QDEL) trims 2026 outlook after Q1 revenue and margin decline - Stock Titan
QuidelOrtho Reports First Quarter 2026 Financial Results - PR Newswire
symbol__ Stock Quote Price and Forecast - CNN
QuidelOrtho (QDEL) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
QuidelOrtho Corp. Hits New 52-Week Low at $10.86 Amid Ongoing Struggles - Markets Mojo
Earnings preview: QuidelOrtho (QDEL) Q1 earnings expected to decline - MSN
LEX Diagnostics acquired by QuidelOrtho Corporation for $100m six years after launch - Cambridge Independent
Earnings Preview: QuidelOrtho to Report Financial Results Post-market on May 05 - Moomoo
QuidelOrtho (QDEL) price target decreased by 18.10% to 29.38 - MSN
Vanguard holds 4,088,168 shares of QuidelOrtho (NASDAQ: QDEL) - Stock Titan
QuidelOrtho (QDEL) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline - Yahoo Finance
QuidelOrtho to discontinue Savanna platform development - MSN
Estuary Capital Management LP's QuidelOrtho Corp(QDEL) Holding History - GuruFocus
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corp (QDEL) Shares Surge 6.1% -- What GF Score of 60 Tells Investors - GuruFocus
[ARS] QuidelOrtho Corp SEC Filing - Stock Titan
[DEF 14A] QuidelOrtho Corp Definitive Proxy Statement - Stock Titan
TTP Group sells LEX Diagnostics to QuidelOrtho to scale PCR tech - MSN
QuidelOrtho (QDEL) drops 20% after-hours on Wednesday—what's going on? - MSN
Why diagnostics names CareDx and QuidelOrtho just diverged - MSN
QuidelOrtho completes $100m acquisition of LEX Diagnostics from TTP - Business Weekly
QuidelOrtho, MIND Technology, Southern First Bancshares and other big stocks moving lower in Thursday's pre-market session - MSN
QuidelOrtho Corp. Opens with 5.51% Gain Amid Ongoing Financial Challenges - Markets Mojo
QuidelOrtho (QDEL) COO reports RSU vesting and tax share withholding - Stock Titan
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$5.72 Million in Common Stock - 富途牛牛
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowWhat's Next? - MarketBeat
Understanding and Addressing Syphilis Trends – and What’s Being Missed - The Malaysian Reserve
QuidelOrtho stock sinks to 52-week lowhere's why - MSN
Understanding and Addressing Syphilis Trendsand What's Being Missed – Company Announcement - Financial Times
QuidelOrtho (NASDAQ:QDEL) Shares Down 7.1%Here's What Happened - MarketBeat
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m - Investors in Healthcare
QuidelOrtho acquires molecular diagnostics firm LEX Diagnostics By Investing.com - Investing.com India
QuidelOrtho completes LEX Diagnostics buy for $100 million By Investing.com - Investing.com India
Quidelortho Corp (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):